EPILEPSY CAUSED BY PCDH19 GENE MUTATION: A REVIEW OF LITERATURE AND THE AUTHORS’ OBSERVATIONS

Cover Page

Cite item

Full Text

Abstract

Mutation in the PCDH19 gene was first described by L.M. Dibbens et al. in 2008. Mutations in this gene are associated with epilepsy and mental retardation limited to females. The clinical manifestations that are observed in some patients with PCDH19 mutation and Dravet syndrome that is caused by mutation in the SCN1A gene include the onset of febrile and afebrile seizures in infancy, serial seizures during fever, and regression in development after the onset of seizures. Due to the fact that the two diseases have common clinical signs, it is best to test for PCDH19 mutation in patients with the clinical picture of Dravet syndrome and a negative test for SCN1A. In general, the number of scientific papers devoted to analysis and recommendations for the choice of therapy in patients with rare genetic pathology is small now. We analyzed the specific features of clinical signs and therapy in our two observed female patients aged 4 and 11 years with verified PCDH19 mutation. Both patients were noted to have severe epilepsy with febrile convulsions with the development of status epilepticus and to be unresponsive to antiepileptic therapy. The use of different antiepileptic drugs (valproate, oxcarbazepine, phenobarbital, topiramate, levetiracetam) at different combinations failed to control the course of epilepsy in the 4-year-old patient whereas the 11-year-old patient who took a combination of valproic acid and benzodiazepines achieved a positive effect.

About the authors

K. Yu. Mukhin

Svt. Luka's Institute of Child Neurology and Epilepsy, Moscow

Author for correspondence.
Email: center@epileptologist.ru

Konstantin Y. Muknin –6 Svetlaya St.,PuchkovoVillage, Pervomayskoe Settlement,Moscow, 143396 

Russian Federation

O. A. Pylaeva

Svt. Luka's Institute of Child Neurology and Epilepsy, Moscow

Email: fake@neicon.ru
6 Svetlaya St.,PuchkovoVillage, Pervomayskoe Settlement,Moscow, 143396 Russian Federation

A. F. Dolinina

Chelyabinsk Regional Children’s Clinical Hospital

Email: fake@neicon.ru
; 42A Blyukhera St., Chelyabinsk, 454076 Russian Federation

S. Moiseeva

Neuropediatric Clinic and Clinic for Neurorehabilitation Epilepsy Center for Children and Adolescents, Schoen Klinik Vogtareuth

Email: fake@neicon.ru
20 Krankenhausstrasse, D-83569, Vogtareuth Germany

Yu. V. Verbitskaya

Svt. Luka's Institute of Child Neurology and Epilepsy, Moscow

Email: fake@neicon.ru
6 Svetlaya St.,PuchkovoVillage, Pervomayskoe Settlement,Moscow, 143396 Russian Federation

A. S. Petrukhin

Russian National Research Medical University, Moscow

Email: fake@neicon.ru

Department of Neurology and Neurosurgery, Faculty of General Medicine, N.I.

1 Ostrovityanova St., Moscow, 117997

Russian Federation

G. Kluger

Neuropediatric Clinic and Clinic for Neurorehabilitation Epilepsy Center for Children and Adolescents, Schoen Klinik Vogtareuth

Email: fake@neicon.ru
20 Krankenhausstrasse, D-83569, Vogtareuth Germany

H. Holthausen

Neuropediatric Clinic and Clinic for Neurorehabilitation Epilepsy Center for Children and Adolescents, Schoen Klinik Vogtareuth

Email: fake@neicon.ru
Контакты: 20 Krankenhausstrasse, D-83569, Vogtareuth Russian Federation

M. Staudt

Neuropediatric Clinic and Clinic for Neurorehabilitation Epilepsy Center for Children and Adolescents, Schoen Klinik Vogtareuth

Email: fake@neicon.ru
20 Krankenhausstrasse, D-83569, Vogtareuth Germany

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 22926 от  12.01.2006.